Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
Title
Grant Type
Focus Area
Country
Application Due Date
Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada, USA
ADVANCE: Global Awards for Advancing Chronic Pain Research
Release Date:
Partner: Eli Lilly and Company
Review Process: Expert Review Panel
Research Internal Medicine All
Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology United Kingdom
New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
Release Date:
Partner: Merck KGaA Darmstadt, Germany and EMD Serono
Review Process: Pfizer Internal
Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
PARP-inhibitor Combination Treatments in Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Remote Mentoring Programs in RCC
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
Release Date:
Partner: The Sharing Progress in Cancer Care (SPCC)
Review Process: Expert Review Panel
Quality Improvement Oncology All
NSCLC Oncogene Driver Considerations in Testing & Treatment
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology Canada, USA
Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
Release Date:
Review Process: Pfizer Internal
Education Oncology Canada, USA
Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology France, Germany